Defined tumor antigen-specific T cells potentiate personalized TCR-T cell therapy and prediction of immunotherapy response.
He J, Xiong X, Yang H, Li D, Liu X, Li S, Liao S, Chen S, Wen X, Yu K, Fu L, Dong X, Zhu K, Xia X, Kang T, Bian C, Li X, Liu H, Ding P, Zhang X, Liu Z, Li W, Zuo Z, Zhou P.
He J, et al. Among authors: li s, li d, li w, li x.
Cell Res. 2022 Jun;32(6):530-542. doi: 10.1038/s41422-022-00627-9. Epub 2022 Feb 14.
Cell Res. 2022.
PMID: 35165422
Free PMC article.